Cochrane Abstracts
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Duration of Treatment With Vitamin K Antagonists in Symptomatic Venous Thromboembolism." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435694/all/Duration_of_treatment_with_vitamin_K_antagonists_in_symptomatic_venous_thromboembolism.
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/all/Duration_of_treatment_with_vitamin_K_antagonists_in_symptomatic_venous_thromboembolism. Accessed April 20, 2026.
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/all/Duration_of_treatment_with_vitamin_K_antagonists_in_symptomatic_venous_thromboembolism
Duration of Treatment With Vitamin K Antagonists in Symptomatic Venous Thromboembolism [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/all/Duration_of_treatment_with_vitamin_K_antagonists_in_symptomatic_venous_thromboembolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
ID - 435694
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/all/Duration_of_treatment_with_vitamin_K_antagonists_in_symptomatic_venous_thromboembolism
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
